BG105826A - Therapeutical formulation for intermittent claudication - Google Patents

Therapeutical formulation for intermittent claudication

Info

Publication number
BG105826A
BG105826A BG105826A BG10582601A BG105826A BG 105826 A BG105826 A BG 105826A BG 105826 A BG105826 A BG 105826A BG 10582601 A BG10582601 A BG 10582601A BG 105826 A BG105826 A BG 105826A
Authority
BG
Bulgaria
Prior art keywords
intermittent claudication
osanetant
pharmaceutically acceptable
production
medicaments
Prior art date
Application number
BG105826A
Other languages
Bulgarian (bg)
English (en)
Inventor
Takeshi KOMIYAMA
Hideaki Kihara
Ken Hirose
Hiroshi Sigematsu
Ryota Yoshimoto
Original Assignee
Ajinomoto Co., Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co., Inc filed Critical Ajinomoto Co., Inc
Publication of BG105826A publication Critical patent/BG105826A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG105826A 1999-02-26 2001-08-16 Therapeutical formulation for intermittent claudication BG105826A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11050150A JP2000247882A (ja) 1999-02-26 1999-02-26 間歇性跛行治療薬
PCT/JP2000/001046 WO2000051604A1 (fr) 1999-02-26 2000-02-24 Remedes contre la claudication intermittente

Publications (1)

Publication Number Publication Date
BG105826A true BG105826A (en) 2002-04-30

Family

ID=12851167

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105826A BG105826A (en) 1999-02-26 2001-08-16 Therapeutical formulation for intermittent claudication

Country Status (19)

Country Link
US (1) US6476049B2 (pt)
EP (1) EP1155693A4 (pt)
JP (1) JP2000247882A (pt)
KR (1) KR20010102388A (pt)
CN (1) CN1407892A (pt)
AU (1) AU2690700A (pt)
BG (1) BG105826A (pt)
BR (1) BR0008543A (pt)
CA (1) CA2373463A1 (pt)
CZ (1) CZ20013048A3 (pt)
HU (1) HUP0200113A3 (pt)
IL (1) IL144892A0 (pt)
MX (1) MXPA01008669A (pt)
NO (1) NO20014125L (pt)
NZ (1) NZ513687A (pt)
SK (1) SK12132001A3 (pt)
WO (1) WO2000051604A1 (pt)
YU (1) YU62101A (pt)
ZA (1) ZA200106782B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000247882A (ja) 1999-02-26 2000-09-12 Ajinomoto Co Inc 間歇性跛行治療薬
EP1430890A4 (en) * 2001-09-26 2007-01-17 Mitsubishi Pharma Corp THROMBUS / THROMBOGENESIS INHIBITORS
CN114796182B (zh) * 2021-01-27 2023-12-12 中国海洋大学 益母草碱在用于制备防治间歇性跛行的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100351012B1 (ko) * 1994-04-20 2002-12-26 아지노모토 가부시키가이샤 피페리딘유도체및이를함유하는항혈소판제
JP2962186B2 (ja) * 1994-04-20 1999-10-12 味の素株式会社 ピペリジン誘導体及びそれを含有するセロトニン拮抗薬
AU6230398A (en) * 1997-02-27 1998-09-18 Ajinomoto Co., Inc. Thrombolytic agent
JP2000247882A (ja) 1999-02-26 2000-09-12 Ajinomoto Co Inc 間歇性跛行治療薬

Also Published As

Publication number Publication date
HUP0200113A2 (en) 2002-06-29
EP1155693A4 (en) 2006-12-27
SK12132001A3 (sk) 2001-12-03
IL144892A0 (en) 2002-06-30
EP1155693A1 (en) 2001-11-21
ZA200106782B (en) 2002-08-16
HUP0200113A3 (en) 2002-12-28
YU62101A (sh) 2004-07-15
MXPA01008669A (es) 2002-03-14
US20020037906A1 (en) 2002-03-28
NO20014125D0 (no) 2001-08-24
US6476049B2 (en) 2002-11-05
AU2690700A (en) 2000-09-21
JP2000247882A (ja) 2000-09-12
CA2373463A1 (en) 2000-09-08
NZ513687A (en) 2001-09-28
NO20014125L (no) 2001-08-24
WO2000051604A1 (fr) 2000-09-08
CN1407892A (zh) 2003-04-02
BR0008543A (pt) 2001-11-06
CZ20013048A3 (cs) 2002-01-16
KR20010102388A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
MXPA03010810A (es) Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
JO2371B1 (en) 4-phenyl-pyridine derivatives
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
HUP0203325A2 (hu) Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO1999012532A3 (en) Piperidine derivatives against malaria
HK1086011A1 (en) Ccr1 antagonists for the treatment of i.a demyelinating inflammatory disease
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
AP2003002929A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
EP1201239A4 (en) CYCLIC AMINES AS CCR3 ANTAGONISTS
SE0202429D0 (sv) Novel Compounds
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
HUP0203597A2 (hu) Zolmitriptant tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
BG105826A (en) Therapeutical formulation for intermittent claudication
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
SE0201837D0 (sv) Chemical compounds
TW200502236A (en) Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents